What AI says about GastroPlus
GastroPlus is a PBPK/PBBM modeling platform from Simulations Plus used to enable model-informed drug development from discovery through regulatory submission. It lets researchers predict structure-to-dose relationships, translate preclinical results to humans, anticipate food effects, quantify drug-drug interactions, support biowaivers and virtual bioequivalence, and run population simulations to de-risk programs. The platform integrates with ADMET Predictor, MonolixSuite, DILIsym, and Pro-ficiency, offers AI-assisted model setup and workflow automation, and connects via API for streamlined, regulator-ready decisions.
AI mentioned GastroPlus from July 2026 to September 2026.
Questions and answers
- Most mentioned
- We want to model toxicity and safety earlier in drug development. Which AI platforms are credible?Schrödinger shares the lead for mentions with 2 more
Excerpts where GastroPlus appeared in the AI's answer
Google AI ModeAug 21, 2026, Google AI Mode It pairs advanced machine learning QSAR/QSPR models directly with GastroPlus high-throughput PBPK
- What tools can integrate ELN, LIMS, robotics, and model outputs into one discovery workflow?Benchling is the most-mentioned brand
GastroPlus in AI answers
We want to model toxicity and safety earlier in drug development. Which AI platforms are credible?
Sites AI cites
AI cited simulations-plus.com in these answers, after intuitionlabs.ai, certara.com, and sapiosciences.com.
Brands AI mentions
AI mentioned GastroPlus most often alongside Certara, ADMET Predictor, and Schrödinger.
